Literature DB >> 29164622

Sino-Nasal outcome test-22 outcomes after sinus surgery: A systematic review and meta-analysis.

Zachary M Soler1, Rabun Jones1, Phong Le1, Luke Rudmik2, Jose L Mattos1, Shaun A Nguyen1, Rodney J Schlosser1.   

Abstract

OBJECTIVES/HYPOTHESIS: The goal of the study was to perform a systematic review with meta-analysis to determine the mean change in the 22-item Sino-Nasal Outcome Test (SNOT-22) across patients who have had endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS) in the literature.
METHODS: A literature search was performed to identify studies that assessed SNOT-22 scores before and after ESS in adult patients with CRS. A random effects model with inverse variance weighting was used to generate the mean change after surgery, along with the forest plot and 95% confidence interval (CI). The impact of patient-specific factors across studies was assessed using a mixed-effects meta-regression.
RESULTS: The final study list included 40 unique patient cohorts published from 2008 to 2016. All studies showed a statistically significant change in mean SNOT-22 scores between baseline and postoperative time points (P < .001), ranging from 12.7 to 44.8, at an average follow-up of 10.6 months. The summary change in mean SNOT-22 across all studies was 24.4 (95% CI: 22.0-26.8). After forward, step-wise multivariate modeling, studies with higher mean preoperative SNOT-22 score and higher asthma prevalence were associated with greater changes in SNOT-22 score after ESS, whereas studies with longer mean follow-up had smaller changes in SNOT-22 score.
CONCLUSIONS: Studies evaluating quality-of-life outcomes after sinus surgery using the SNOT-22 instrument universally show significant improvement after ESS. Across the published literature, the magnitude of change is quite variable and appears to be influenced by a number of factors including baseline SNOT-22 score, asthma prevalence, and length of follow-up. Laryngoscope, 128:581-592, 2018.
© 2017 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  22-item Sino-Nasal Outcome Test; Chronic rhinosinusitis; meta-analysis; quality improvement; quality of life

Mesh:

Year:  2017        PMID: 29164622      PMCID: PMC5814358          DOI: 10.1002/lary.27008

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  90 in total

1.  Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit.

Authors:  S Abdalla; H Alreefy; C Hopkins
Journal:  Clin Otolaryngol       Date:  2012-08       Impact factor: 2.597

2.  Outcomes of chronic frontal sinusitis treated with ethmoidectomy: a prospective study.

Authors:  Waleed M Abuzeid; Jess C Mace; Milena L Costa; Luke Rudmik; Zachary M Soler; Grace S Kim; Timothy L Smith; Peter H Hwang
Journal:  Int Forum Allergy Rhinol       Date:  2016-02-16       Impact factor: 3.858

3.  Health-related quality of life after polypectomy with and without additional surgery.

Authors:  John Patrick Browne; Claire Hopkins; Robert Slack; John Topham; Barnaby Reeves; Valerie Lund; Peter Brown; Lynn Copley; Jan van der Meulen
Journal:  Laryngoscope       Date:  2006-02       Impact factor: 3.325

4.  Evaluation of chronic rhinosinusitis management using the SNOT-22 in adult cystic fibrosis patients.

Authors:  V Savastano; S Bertin; T Vittori; C Tripodi; G Magliulo
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014       Impact factor: 3.507

5.  Hyperostotic chronic sinusitis as an indication for outpatient intravenous antibiotics.

Authors:  Madeleine R Schaberg; Vijay K Anand; Ameet Singh
Journal:  Laryngoscope       Date:  2010       Impact factor: 3.325

6.  Meticulous endoscopic sinus surgery to prevent recurrence of massive nasal polyposis.

Authors:  S M S Hoseini; B Saedi; K Aghazadeh
Journal:  J Laryngol Otol       Date:  2012-08       Impact factor: 1.469

7.  The role of immediate postoperative systemic corticosteroids when utilizing a steroid-eluting spacer following sinus surgery.

Authors:  Jon F Dautremont; Brad Mechor; Luke Rudmik
Journal:  Otolaryngol Head Neck Surg       Date:  2014-01-30       Impact factor: 3.497

8.  Gender-specific differences in chronic rhinosinusitis patients electing endoscopic sinus surgery.

Authors:  Devyani Lal; Alexis B Rounds; Rohit Divekar
Journal:  Int Forum Allergy Rhinol       Date:  2015-11-17       Impact factor: 3.858

Review 9.  Patient-reported outcome measures for adult chronic rhinosinusitis: A systematic review and quality assessment.

Authors:  Luke Rudmik; Claire Hopkins; Anju Peters; Timothy L Smith; Rodney J Schlosser; Zachary M Soler
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

10.  The effect of functional endoscopic sinus surgery on patients with asthma and CRS with nasal polyps.

Authors:  E Proimos; C E Papadakis; T S Chimona; D Kiagiadaki; E Ferekidis; J Yiotakis
Journal:  Rhinology       Date:  2010-09       Impact factor: 3.681

View more
  15 in total

1.  Advanced age adversely affects chronic rhinosinusitis surgical outcomes.

Authors:  Kristen L Yancey; Anne S Lowery; Rakesh K Chandra; Naweed I Chowdhury; Justin H Turner
Journal:  Int Forum Allergy Rhinol       Date:  2019-08-27       Impact factor: 3.858

2.  Socioeconomic status impacts postoperative productivity loss and health utility changes in refractory chronic rhinosinusitis.

Authors:  Daniel M Beswick; Jess C Mace; Zachary M Soler; Luke Rudmik; Jeremiah A Alt; Kristine A Smith; Kara Y Detwiller; Vijay R Ramakrishnan; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2019-06-27       Impact factor: 3.858

3.  Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP.

Authors:  Shunsuke Minagawa; Jun Araya; Naoaki Watanabe; Shota Fujimoto; Junko Watanabe; Hiromichi Hara; Takanori Numata; Kazuyoshi Kuwano; Yoshinori Matsuwaki
Journal:  BMC Pulm Med       Date:  2022-06-28       Impact factor: 3.320

4.  Lack of impact of radiologic septal measurements upon patient symptoms and performance of septoplasty during endoscopic sinus surgery.

Authors:  N R Rowan; Z M Soler; J C Mace; M P Camilon; C Palmer; R H Jones; T L Smith; R J Schlosser
Journal:  Rhinology       Date:  2020-08-01       Impact factor: 3.681

5.  Acute Exacerbations in Recurrent Acute Rhinosinusitis: Differences in Quality of Life and Endoscopy.

Authors:  Daniel M Beswick; Noel F Ayoub; Jess C Mace; Alia Mowery; Peter H Hwang; Timothy L Smith
Journal:  Laryngoscope       Date:  2019-12-14       Impact factor: 3.325

6.  The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights.

Authors:  D Dejaco; D Riedl; A Huber; R Moschen; A I Giotakis; L Bektic-Tadic; T Steinbichler; P Kahler; H Riechelmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-09       Impact factor: 2.503

7.  A structured histopathology-based analysis of surgical outcomes in chronic rhinosinusitis with and without nasal polyps.

Authors:  Michael J Marino; J Omar Garcia; Matthew Zarka; Devyani Lal
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-08-21

8.  Disease control after surgery for chronic rhinosinusitis: prospective, multi-institutional validation of the Sinus Control Test.

Authors:  Ryan E Little; Rodney J Schlosser; Timothy L Smith; Kristina A Storck; Jeremiah A Alt; Daniel M Beswick; Jess C Mace; Jose L Mattos; Vijay R Ramakrishnan; Zachary M Soler
Journal:  Int Forum Allergy Rhinol       Date:  2020-07-26       Impact factor: 3.858

Review 9.  Management of Chronic Rhinosinusitis with Nasal Polyposis in the Era of Biologics.

Authors:  Justin C Morse; Craig Miller; Brent Senior
Journal:  J Asthma Allergy       Date:  2021-07-12

10.  Prognostic value of the Sinonasal Outcome Test 22 (SNOT-22) in chronic rhinosinusitis.

Authors:  Stefania Gallo; Federico Russo; Francesco Mozzanica; Andrea Preti; Francesco Bandi; Cecilia Costantino; Roberto Gera; Francesco Ottaviani; Paolo Castelnuovo
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.